Tiny study tests if DNA can decide how much thyroid to remove
NCT ID NCT06235814
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested whether routine genetic analysis of thyroid cancer samples could help surgeons decide how much of the thyroid to remove. Only 2 patients were enrolled. The goal was to see if a larger trial is possible, not to change treatment yet.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this approach could help doctors decide whether to remove part or all of the thyroid gland based on the cancer's genetic risk, potentially avoiding unnecessary surgery.
- What could go wrong
- This was a very small pilot study with only 2 participants, so results may not apply broadly. The main goal was to test feasibility, not to prove the approach works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAPILLARY THYROID CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California Los Angeles
Los Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Real-Time tissue test may help surgeons avoid unnecessary neck dissections in thyroid cancer
- Hidden thyroid cancers: how common are they in patients with thyroiditis?
- New thyroid test aims to cut unnecessary surgeries
- Radioactive iodine: unnecessary for some thyroid cancer patients?
- Pee power: urine test could replace blood draws for thyroid cancer Follow-Up
- Urine test may spot hidden thyroid cancer, avoid unnecessary surgery